Detalhe da pesquisa
1.
Efficacy, Safety and Quality of Life of Pegcetacoplan in Japanese Patients With Paroxysmal Nocturnal Hemoglobinuria Treated Within the Phase 3 PEGASUS Trial.
Acta Haematol
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615657
2.
Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders.
Haemophilia
; 29(1): 377-381, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469854
3.
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment.
Ann Rheum Dis
; 75(2): 362-7, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25475116
4.
Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders.
Haemophilia
; 27(4): e554-e558, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33982353
5.
Safety and tolerability of dexmecamylamine (TC-5214) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to antidepressant therapy: results of a long-term study.
J Clin Psychopharmacol
; 35(1): 77-81, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25514064
6.
Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
Int J Neuropsychopharmacol
; 16(8): 1755-65, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23672772
7.
Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
Int J Neuropsychopharmacol
; 16(8): 1733-44, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23673347
8.
Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand.
Res Pract Thromb Haemost
; 7(6): 102163, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37720484
9.
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies.
Hum Psychopharmacol
; 26(8): 614-28, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22143997
10.
Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study.
Lancet Diabetes Endocrinol
; 9(7): 427-435, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023005
11.
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial.
Lancet Diabetes Endocrinol
; 8(9): 762-772, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822600
12.
Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.
CNS Spectr
; 14(6): 299-313, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19668121
13.
Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.
BMJ Open
; 9(5): e028012, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152037
14.
Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia B.
Res Pract Thromb Haemost
; 3(1): 109-113, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30656283
15.
Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania.
J Comp Eff Res
; 4(1): 51-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25168473
16.
Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.
World J Biol Psychiatry
; 16(7): 483-501, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25602163
17.
Relationship Between Serum Concentrations of Nitisinone and Its Effect on Homogentisic Acid and Tyrosine in Patients with Alkaptonuria.
JIMD Rep
; 24: 21-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25772318
18.
Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
Int Clin Psychopharmacol
; 29(2): 93-105, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24162081
19.
Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.
J Clin Psychiatry
; 75(5): 520-7, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24816198
20.
Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study.
Int J Bipolar Disord
; 2: 14, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25505693